» Articles » PMID: 27297388

Murine Alveolar Macrophages Are Highly Susceptible to Replication of Coxiella Burnetii Phase II In Vitro

Overview
Journal Infect Immun
Date 2016 Jun 15
PMID 27297388
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Coxiella burnetii is a Gram-negative bacterium that causes Q fever in humans. Q fever is an atypical pneumonia transmitted through inhalation of contaminated aerosols. In mammalian lungs, C. burnetii infects and replicates in several cell types, including alveolar macrophages (AMs). The innate immunity and signaling pathways operating during infection are still poorly understood, in part because of the lack of relevant host cell models for infection in vitro In the study described here, we investigated and characterized the infection of primary murine AMs by C. burnetii phase II in vitro Our data reveal that AMs show a pronounced M2 polarization and are highly permissive to C. burnetii multiplication in vitro Murine AMs present an increased susceptibility to infection in comparison to primary bone marrow-derived macrophages. AMs support more than 2 logs of bacterial replication during 12 days of infection in culture, similar to highly susceptible host cells, such as Vero and THP-1 cells. As a proof of principle that AMs are useful for investigation of C. burnetii replication, we performed experiments with AMs from Nos2(-/-) or Ifng(-/-) mice. In the absence of gamma interferon and nitric oxide synthase 2 (NOS2), AMs were significantly more permissive than wild-type cells. In contrast, AMs from Il4(-/-) mice were more restrictive to C. burnetii replication, supporting the importance of M2 polarization for the permissiveness of AMs to C. burnetii replication. Collectively, our data account for understanding the high susceptibility of alveolar macrophages to bacterial replication and support the use of AMs as a relevant model of C. burnetii growth in primary macrophages.

Citing Articles

Immunobiotic FFIG58 Confers Long-Term Protection against .

Elean M, Tonetti F, Fukuyama K, Arellano-Arriagada L, Namai F, Suda Y Int J Mol Sci. 2023; 24(21).

PMID: 37958756 PMC: 10648150. DOI: 10.3390/ijms242115773.


Engineering Protein Nanoparticles Functionalized with an Immunodominant Antigen to Generate a Q Fever Vaccine.

Ramirez A, Felgner J, Jain A, Jan S, Albin T, Badten A Bioconjug Chem. 2023; 34(9):1653-1666.

PMID: 37682243 PMC: 10515490. DOI: 10.1021/acs.bioconjchem.3c00317.


co-opts the Glutathione Peroxidase 4 to protect the host cell from oxidative stress-induced cell death.

Loterio R, Thomas D, Andrade W, Lee Y, Santos L, Mascarenhas D Proc Natl Acad Sci U S A. 2023; 120(36):e2308752120.

PMID: 37639588 PMC: 10483631. DOI: 10.1073/pnas.2308752120.


Multivalent vaccines demonstrate immunogenicity and protect against aerosol challenge.

Jan S, Fratzke A, Felgner J, Hernandez-Davies J, Liang L, Nakajima R Front Immunol. 2023; 14:1192821.

PMID: 37533862 PMC: 10390735. DOI: 10.3389/fimmu.2023.1192821.


Bovine blood derived macrophages are unable to control replication under hypoxic conditions.

Mauermeir M, Olke M, Hayek I, Schulze-Luehrmann J, Dettmer K, Oefner P Front Immunol. 2023; 14:960927.

PMID: 36793725 PMC: 9923158. DOI: 10.3389/fimmu.2023.960927.


References
1.
Dinakar C, Malur A, Raychaudhuri B, Buhrow L, Melton A, Kavuru M . Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide. Ann Allergy Asthma Immunol. 1999; 82(2):217-22. DOI: 10.1016/S1081-1206(10)62600-2. View

2.
van Loenhout J, Wielders C, Morroy G, Cox M, van der Hoek W, Hautvast J . Severely impaired health status of non-notified Q fever patients leads to an underestimation of the true burden of disease. Epidemiol Infect. 2015; 143(12):2580-7. PMC: 9151036. DOI: 10.1017/S0950268814003689. View

3.
Brennan R, Russell K, Zhang G, Samuel J . Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections. Infect Immun. 2004; 72(11):6666-75. PMC: 523001. DOI: 10.1128/IAI.72.11.6666-6675.2004. View

4.
Graham J, MacDonald L, Hussain S, Sharma U, Kurten R, Voth D . Virulent Coxiella burnetii pathotypes productively infect primary human alveolar macrophages. Cell Microbiol. 2013; 15(6):1012-25. PMC: 3655087. DOI: 10.1111/cmi.12096. View

5.
Beare P, Gilk S, Larson C, Hill J, Stead C, Omsland A . Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages. mBio. 2011; 2(4):e00175-11. PMC: 3163939. DOI: 10.1128/mBio.00175-11. View